Clinical Trials Directory

Trials / Completed

CompletedNCT01115595

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais

Efficacy of Mite Allergen Vaccine Among Thai Patients With Allergic Rhinitis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
84 (actual)
Sponsor
Pongsakorn Tantilipikorn · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to study the efficacy of allergen injection immunotherapy for allergic rhinitis by * symptoms score * medication score * quality of life * immunologic test from blood

Detailed description

Compare the efficacy of allergen injection immunotherapy between the treatment group and the placebo group after injection for * 2 months * 6 months * 12 months

Conditions

Interventions

TypeNameDescription
BIOLOGICALInterventionDermatophagoides pteronyssinus from ALK company
OTHERControlInjection by buffer solution WITH standard allergic medication (oral antihistamine and/or topical nasal steroid)

Timeline

Start date
2010-03-01
Primary completion
2013-10-01
Completion
2014-10-01
First posted
2010-05-04
Last updated
2019-03-18

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01115595. Inclusion in this directory is not an endorsement.

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais (NCT01115595) · Clinical Trials Directory